Cellbiotech
KOSDAQ · Healthcare · ₩144B
₩15,300+0.20%
Price
16,340원
15,300원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩15.8B+8.3%
Operating Income₩1.6B-48.5%
Net Income₩3.6B-32.6%
3/'26 vs prev quarter
Company Health
Market Cap₩144B
Operating Margin+16.7%
Short Volume 2.5% · as of 26.09.11
Among 34 바이오 peers
LowMedianHigh
PSR2.4xmedian 6.7xPER8.6xmedian 21.8x
